Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00888459 · ClinicalTrials.gov registry record · Phase 2
A Pilot Study Evaluating Nicotine Lozenges and Self Help
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00888459: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT00888459 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00888459, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The investigators are hypothesizing that by offering both self-help materials and mailed nicotine lozenges we will be able to help increase tobacco abstinence rates among ST users, as well as decrease tobacco withdrawal.
Interventions
- DRUG nicotine replacement therapy
- DRUG placebo NRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00888459
The ClinicalTrials.gov registry entry for NCT00888459 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which nicotine replacement therapy is the first listed.
NCT00888459 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00888459 about?
NCT00888459 is a clinical study titled "A Pilot Study Evaluating Nicotine Lozenges and Self Help". The investigators are hypothesizing that by offering both self-help materials and mailed nicotine lozenges we will be able to help increase tobacco abstinence rates among ST users, as well as decrease tobacco withdrawal.
What is the current status of trial NCT00888459?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2008-04. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00888459?
The interventions under investigation include: nicotine replacement therapy (DRUG), placebo NRT (DRUG).
Who is sponsoring clinical trial NCT00888459?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.